Aerovate Therapeutics, Inc. (AVTE)
NASDAQ: AVTE · Real-Time Price · USD
2.790
+0.340 (13.88%)
At close: Nov 1, 2024, 4:00 PM
2.731
-0.059 (-2.11%)
After-hours: Nov 1, 2024, 7:02 PM EDT
Aerovate Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Selling, General & Admin | 18.19 | 17.19 | 14.62 | 8.04 | 0.95 | 0.22 |
Research & Development | 76.03 | 64.22 | 38.62 | 14.99 | 7.94 | 3.11 |
Operating Expenses | 94.22 | 81.41 | 53.24 | 23.02 | 8.89 | 3.33 |
Operating Income | -94.22 | -81.41 | -53.24 | -23.02 | -8.89 | -3.33 |
Interest Expense | - | - | - | - | -0.08 | - |
Interest & Investment Income | 6.34 | 5.95 | 1.83 | 0.07 | - | - |
Other Non Operating Income (Expenses) | -0.01 | -0 | -0.08 | -0 | -0 | 0 |
EBT Excluding Unusual Items | -87.88 | -75.47 | -51.49 | -22.96 | -8.97 | -3.33 |
Other Unusual Items | - | - | - | - | -0.64 | - |
Pretax Income | -87.88 | -75.47 | -51.49 | -22.96 | -9.61 | -3.33 |
Income Tax Expense | 0.06 | 0.06 | 0.03 | 0 | - | 0 |
Net Income | -87.94 | -75.52 | -51.51 | -22.96 | -9.61 | -3.33 |
Preferred Dividends & Other Adjustments | - | - | - | 0.02 | 0.15 | - |
Net Income to Common | -87.94 | -75.52 | -51.51 | -22.99 | -9.76 | -3.33 |
Shares Outstanding (Basic) | 28 | 26 | 24 | 12 | 0 | 0 |
Shares Outstanding (Diluted) | 28 | 26 | 24 | 12 | 0 | 0 |
Shares Change (YoY) | 13.63% | 7.60% | 99.06% | 4975.15% | 0.32% | - |
EPS (Basic) | -3.13 | -2.87 | -2.10 | -1.87 | -40.31 | -13.79 |
EPS (Diluted) | -3.13 | -2.87 | -2.10 | -1.87 | -40.31 | -13.79 |
Free Cash Flow | -74.61 | -56.92 | -39.32 | -27.58 | -7.86 | -2.78 |
Free Cash Flow Per Share | -2.65 | -2.16 | -1.61 | -2.24 | -32.44 | -11.52 |
EBITDA | -94.11 | -81.31 | -53.17 | -23.01 | -8.89 | - |
D&A For EBITDA | 0.11 | 0.1 | 0.07 | 0.02 | 0 | - |
EBIT | -94.22 | -81.41 | -53.24 | -23.02 | -8.89 | -3.33 |
Source: S&P Capital IQ. Standard template.
Financial Sources.